The molecular biology of pancreatic cancer
Affiliations
- PMID: 19360152
- PMCID: PMC2666839
Item in Clipboard
The molecular biology of pancreatic cancer
Gastrointest Cancer Res.
2007.
Abstract
Pancreatic cancer is the fourth leading cause of cancer-related death in the United States. It is a highly aggressive malignancy for which currently available treatments are of only limited efficacy. For this reason, much research is directed at elucidating fundamental molecular mechanisms underlying the biology of pancreatic cancer. These efforts are generating a rapidly growing body of information. The yet unmet challenge is to translate this information into clinically applicable strategies for early detection, prediction of prognosis, and effective therapies for patients diagnosed with pancreatic cancer.
Similar articles
-
Current and Future Trends in Early Detection of Pancreatic Cancer: Molecular Targets and PET Probes.Curr Med Chem. 2015;22(29):3370-89. doi: 10.2174/0929867322666150821094015. Curr Med Chem. 2015. PMID: 26295468 Review.
-
Control of Apoptosis in Treatment and Biology of Pancreatic Cancer.J Cell Biochem. 2016 Feb;117(2):279-88. doi: 10.1002/jcb.25284. J Cell Biochem. 2016. PMID: 26206252 Free PMC article. Review.
-
Endoscopic management of pain in pancreatic cancer.JOP. 2015 Jan 31;16(1):33-40. doi: 10.6092/1590-8577/2890. JOP. 2015. PMID: 25640780
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Molecular mechanisms of pancreatic cancer.Trop Gastroenterol. 2005 Jul-Sep;26(3):111-4. Trop Gastroenterol. 2005. PMID: 16512456 Review.
Cited by
-
Human pancreatic cancer progression: an anarchy among CCN-siblings.J Cell Commun Signal. 2016 Sep;10(3):207-216. doi: 10.1007/s12079-016-0343-9. Epub 2016 Aug 19. J Cell Commun Signal. 2016. PMID: 27541366 Free PMC article.
-
Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes.Cancer Med. 2020 Nov;9(22):8480-8490. doi: 10.1002/cam4.3477. Epub 2020 Sep 30. Cancer Med. 2020. PMID: 32997898 Free PMC article.
-
Peptide-Based Therapeutics for Oncology.Pharmaceut Med. 2019 Feb;33(1):9-20. doi: 10.1007/s40290-018-0261-7. Pharmaceut Med. 2019. PMID: 31933267 Review.
-
Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC.J Clin Pathol. 2021 Jan;74(1):19-24. doi: 10.1136/jclinpath-2020-206607. Epub 2020 May 8. J Clin Pathol. 2021. PMID: 32385139 Free PMC article.
-
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.Cancers (Basel). 2023 Jan 5;15(2):351. doi: 10.3390/cancers15020351. Cancers (Basel). 2023. PMID: 36672301 Free PMC article. Review.
References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130. - PubMed
-
- Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363:1049–1057. - PubMed
-
- Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485–492. - PubMed
-
- Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol. 2005;23:4524–4531. - PubMed
-
- Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev. 2000;26:29–52. - PubMed
LinkOut - more resources
Full Text Sources